Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity
暂无分享,去创建一个
A. Broocks | P. Rieckmann | H. Tumani | S. Poser | W. Lüer | T. Weber | A. Helwig | B. Kitze | M. Albrecht | MD P. Rieckmann | BA M.Albrecht | MD B. Kitze | '. A. Broocks | W. Luer | '. A. Helwig | MD S. Poser
[1] A. Broocks,et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis , 1994, Neurology.
[2] J. Taubenberger,et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.
[3] A. Weinberg,et al. Lymphokine mRNA expression in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis is associated with a host recruited CD45R hi/CD4+ population during recovery , 1993, Journal of Neuroimmunology.
[4] C. Orosz,et al. DETECTION OF CYTOKINE mRNA IN VIVO BY POLYMERASE CHAIN REACTION: PROBLEMS AND SOLUTIONS , 1993, Transplantation.
[5] M. Huberman,et al. Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis , 1993, Journal of the Neurological Sciences.
[6] H. Hartung. Immune‐mediated demyelination , 1993, Annals of neurology.
[7] G. Pizzolato,et al. Immunopathological changes in human cerebral malaria. , 1993, Clinical neuropathology.
[8] D. Paty,et al. Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.
[9] C. Poser. The pathogenesis of multiple sclerosis , 1993, Journal of the Neurological Sciences.
[10] R. McCarron,et al. Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells , 1993, Journal of Neuroimmunology.
[11] G. Grau,et al. Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis. , 1992, European cytokine network.
[12] K. Mohler,et al. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. , 1992, Journal of immunology.
[13] B. Bloom,et al. Cytokine patterns of immunologically mediated tissue damage. , 1992, Journal of immunology.
[14] E. Thompson,et al. In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis , 1992, Journal of Neuroimmunology.
[15] R. Rudick,et al. Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity. , 1992, Archives of neurology.
[16] V. Barnaba,et al. Tumour necrosis factor‐alpha synthesis by cerebrospinal‐fluid‐derived T cell clones from patients with multiple sclerosis , 1991, Italian journal of neurological sciences.
[17] Y. Shimamoto,et al. Human tumor necrosis factor-α augments experimental allergic encephalomyelitis in rats , 1991, Journal of Neuroimmunology.
[18] A. Cross,et al. Anti—tumor necrosis factor therapy abrogates autoimmune demyelination , 1991, Annals of neurology.
[19] K. Flanders,et al. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1. , 1991, Journal of immunology.
[20] M. Sharief,et al. Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis , 1991 .
[21] C. Raine. Multiple sclerosis: a pivotal role for the T cell in lesion development , 1991, Neuropathology and applied neurobiology.
[22] J. Trotter,et al. Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-α levels , 1991, Journal of Neuroimmunology.
[23] A. Reder,et al. Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis , 1991, Journal of Neuroimmunology.
[24] C. Brosnan,et al. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.
[25] W. Tourtellotte,et al. Serum and CSF levels of IL‐2, sIL‐2R, TNF‐α, and IL‐1β in chronic progressive multiple sclerosis , 1991, Neurology.
[26] R. Clark,et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.
[27] R J Albertini,et al. T cells responsive to myelin basic protein in patients with multiple sclerosis. , 1990, Science.
[28] J. Merrill,et al. Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.
[29] B. Tavolato,et al. Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours , 1989, Journal of Neuroimmunology.
[30] H. Weiner,et al. MS: a CNS and systemic autoimmune disease. , 1989, Immunology today.
[31] H. Kirchner,et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations? , 1988, Acta neurologica Scandinavica.
[32] W. Mcdonald. The mystery of the origin of multiple sclerosis. , 1986, Journal of neurology, neurosurgery, and psychiatry.
[33] B. Waksman. Human disease: Mechanisms in multiple sclerosis , 1985, Nature.
[34] J. Kurtzke. Rating neurologic impairment in multiple sclerosis , 1983, Neurology.
[35] E. Reinherz,et al. Multiple sclerosis Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages , 1983, Journal of Neuroimmunology.
[36] D. Silberberg,et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.